We identified a novel mutation in members of a family with signs of Crouzon syndrome and plagiocephaly. In affected members of the family an A-4G transition was found at position 886 in exon 5 of the fibroblast growth factor receptor 2 (FGFR2) gene. The base change results in the replacement of a lysine by glutamic acid in Ig-like loop III of FGFR2. The unusual finding of plagiocephaly in these Crouzon patients may either be the result of the type of mutation or because of genetic and environmental factors that affect the phenotype in addition to the mutated FGF receptor.
Crouzon syndrome is a clinically defined craniofacial dysostosis characterised by ocular proptosis owing to shallow orbits, hypertelorism, and craniosynostosis. Craniosynostosis is commonly caused by premature Here we describe a novel mutation in exon 5 of FGFR2 in a family with Crouzon syndrome and plagiocephaly. Since plagiocephaly is not normally a finding in clinically defined Crouzon syndrome, the present study supports the idea that eponymous craniosynostosis syndromes are phenotypic extremes of FGFR mutations rather than nosological entities.
EDTA blood was obtained from all subjects shown in the pedigree (fig 1) no abnormalities of either hands or feet. His big toes were somewhat broadened (fig 2) . I.3 was the unaffected sister of I.1 and I.2. III.1 was the 6 month old son of I1.1. At 6 weeks of age he presented with severe dolichocephaly, anterior plagiocephaly, proptosis, and hypertelorism (fig 3) .
Radiography showed premature closure of the sagittal and the right coronal suture resulting in right anterior plagiocephaly. At surgery at 5 months of age, synostosis was found of both coronal sutures in addition to the sagittal suture. There were early signs of premature closure of the lambdoid sutures. Intracranial pressure was slightly increased. There were no neurological abnormalities. Hands and feet were normal. SSCP analysis of exon 5 showed band shifts in all affected but not in unaffected members of the pedigree in fig 1 (not shown) . An A-*G transition at position 886 (codon 292) was found by sequencing of exon 5 in the affected subjects (fig 4) . Both the wild type and the mutated nucleotide were equally pronounced on cycle sequencing in all affected subjects. There is no evidence of mosaicism in any of the patients. The base change results in the replacement of a lysine by glutamic acid in the first third of Ig-like chain III of FGFR2. The exchange of the basic amino acid lysine for the acidic glutamic acid probably alters structural integrity and thus the function of the receptor.
Although the mutation at codon 292 described here has not previously been recognised in autosomal dominant craniosynostosis, many point mutations at different positions of exons 5 and 7 of FGFR2 are known.7'3 These two exons code for Ig-like chain III of FGFR2 that is required for ligand binding. 20 
